Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Gamucci · SciRah

Researcher profile · Semantic Scholar

T. Gamucci

Share profile

T. Gamucci — researcher profile on SciRah

h-index: 40
Works: 234
Citations: 6,810

Most-cited papers

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Miguel Martín, F. Holmes, B. Ejlertsen, S. Delaloge +496 more
2017The Lancet Oncology512 citations
Semantic Scholar
Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study
M. Muscaritoli, S. Lucia, A. Farcomeni, V. Lorusso +26 more
2017OncoTarget404 citations Open access
Semantic Scholar
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
C. Cremolini, C. Antoniotti, D. Rossini, S. Lonardi +78 more
2020The Lancet Oncology239 citations Open access
Semantic Scholar
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
V. Graziano, A. Grassadonia, Laura Iezzi, P. Vici +13 more
2019Breast169 citations Open access
Semantic Scholar
Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life.
M. Maltoni, E. Scarpi, M. Dall'Agata, S. Schiavon +55 more
2016European Journal of Cancer157 citations Open access
Semantic Scholar
Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids.
O. Corli, I. Floriani, A. Roberto, M. Montanari +51 more
2016Annals of Oncology143 citations Open access
Semantic Scholar
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives
E. Krasniqi, G. Barchiesi, L. Pizzuti, M. Mazzotta +16 more
2019Journal of Hematology & Oncology114 citations Open access
Semantic Scholar
Use of nivolumab in elderly patients with advanced squamous non-small-cell lung cancer: results from the Italian cohort of an expanded access programme.
F. Grossi, L. Crinò, A. Logroscino, S. Canova +17 more
2018European Journal of Cancer103 citations
Semantic Scholar
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies
P. Vici, L. Pizzuti, L. Mariani, G. Zampa +19 more
2016Expert Review of Vaccines100 citations Open access
Semantic Scholar
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials
A. Grassadonia, I. Sperduti, P. Vici, Laura Iezzi +10 more
2018Journal of Clinical Medicine97 citations Open access
Semantic Scholar
Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives
G. Barchiesi, M. Mazzotta, E. Krasniqi, L. Pizzuti +13 more
2020International Journal of Molecular Sciences70 citations Open access
Semantic Scholar
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience
P. Vici, L. Pizzuti, A. Michelotti, I. Sperduti +44 more
2017OncoTarget61 citations Open access
Semantic Scholar
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives
Michela Roberto, A. Astone, A. Botticelli, L. Carbognin +18 more
2021Cancers57 citations Open access
Semantic Scholar
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial.
D. Lorusso, G. Scambia, S. Pignata, R. Sorio +14 more
2016Annals of Oncology56 citations Open access
Semantic Scholar
Systematic vs. on-demand early palliative care in gastric cancer patients: a randomized clinical trial assessing patient and healthcare service outcomes
E. Scarpi, M. Dall'Agata, V. Zagonel, T. Gamucci +22 more
2018Supportive Care in Cancer50 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy in triple‐negative breast cancer: A multicentric retrospective observational study in real‐life setting
T. Gamucci, L. Pizzuti, I. Sperduti, L. Mentuccia +26 more
2018Journal of Cellular Physiology45 citations
Semantic Scholar
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population.
L. Crinò, P. Bidoli, A. Delmonte, F. Grossi +16 more
2019The Oncologist40 citations Open access
Semantic Scholar
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study
T. Gamucci, L. Pizzuti, C. Natoli, L. Mentuccia +45 more
2018Cancer Biology & Therapy40 citations Open access
Semantic Scholar
“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome
P. Vici, L. Pizzuti, I. Sperduti, A. Frassoldati +29 more
2016OncoTarget39 citations Open access
Semantic Scholar
Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey.
N. Tinari, C. Fanizza, M. Romero, E. Gambale +16 more
2015Clinical Breast Cancer39 citations Open access
Semantic Scholar
Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment
S. Buglioni, P. Vici, D. Sergi, L. Pizzuti +18 more
2016Oncoimmunology36 citations Open access
Semantic Scholar
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study
A. Grassadonia, P. Di Marino, C. Ficorella, A. Cortellini +12 more
2019Journal of Cancer32 citations Open access
Semantic Scholar
Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy
P. Vici, Cristiana Ercolani, A. di Benedetto, L. Pizzuti +11 more
2016Journal of experimental & clinical cancer research : CR31 citations Open access
Semantic Scholar
PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy
F. Cognetti, R. Masetti, A. Fabi, G. Bianchi +27 more
2021npj Breast Cancer27 citations Open access
Semantic Scholar
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence
E. Krasniqi, L. Pizzuti, Giacomo Barchiesi, D. Sergi +64 more
2020Journal of Cellular Physiology27 citations
Semantic Scholar
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience
L. Pizzuti, A. Giordano, A. Michelotti, M. Mazzotta +64 more
2018Journal of Cellular Physiology24 citations Open access
Semantic Scholar
Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis
R. Grande, C. Natoli, F. Ciancola, D. Gemma +16 more
2016PLoS ONE22 citations Open access
Semantic Scholar
Early Integration of Palliative Care in Oncology Practice: Results of the Italian Association of Medical Oncology (AIOM) Survey
V. Zagonel, R. Torta, V. Franciosi, A. Brunello +24 more
2016Journal of Cancer21 citations Open access
Semantic Scholar
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
E. Krasniqi, A. Sacconi, D. Marinelli, L. Pizzuti +20 more
2021Biomarker Research20 citations Open access
Semantic Scholar
Position Paper of the Italian Association of Medical Oncology on Early Palliative Care in Oncology Practice (Simultaneous Care)
V. Zagonel, V. Franciosi, A. Brunello, G. Biasco +28 more
2017Tumori20 citations Open access
Semantic Scholar
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
N. Colombo, A. Gadducci, J. Sehouli, E. Rulli +167 more
2023British Journal of Cancer19 citations Open access
Semantic Scholar
Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios
L. Pizzuti, E. Krasniqi, G. Barchiesi, M. Mazzotta +15 more
2019Journal of Cancer19 citations Open access
Semantic Scholar
Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy
Cristiana Ercolani, A. di Benedetto, I. Terrenato, L. Pizzuti +14 more
2017Cancer Biology & Therapy19 citations Open access
Semantic Scholar
Bevacizumab as First-Line Treatment in HER2-Negative Advanced Breast Cancer: Pros and Cons
V. Sini, A. Cassano, D. Corsi, M. de Laurentiis +9 more
2016Tumori19 citations Open access
Semantic Scholar
Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis
P. Vici, A. di Benedetto, Cristiana Ercolani, L. Pizzuti +18 more
2015OncoTarget19 citations Open access
Semantic Scholar
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial
L. Pizzuti, M. Barba, M. Mazzotta, E. Krasniqi +52 more
2021Scientific Reports18 citations Open access
Semantic Scholar
A Real‐World Multicentre Retrospective Study of Paclitaxel‐Bevacizumab and Maintenance Therapy as First‐Line for HER2‐Negative Metastatic Breast Cancer
T. Gamucci, L. Mentuccia, C. Natoli, I. Sperduti +27 more
2016Journal of Cellular Physiology18 citations Open access
Semantic Scholar
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience.
L. Moscetti, P. Vici, T. Gamucci, C. Natoli +18 more
2016Breast18 citations Open access
Semantic Scholar
Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials
D. Marinelli, M. Mazzotta, L. Pizzuti, E. Krasniqi +13 more
2020Cancers17 citations Open access
Semantic Scholar
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study
L. Pizzuti, P. Marchetti, C. Natoli, T. Gamucci +21 more
2017Scientific Reports17 citations Open access
Semantic Scholar
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study.
A. Cortellini, M. Bersanelli, S. Buti, E. Gambale +19 more
2018Immunotherapy16 citations Open access
Semantic Scholar
Long-term outcome of breast cancer patients with pathologic N3a lymph node stage.
A. Grassadonia, P. Vici, T. Gamucci, L. Moscetti +9 more
2017Breast15 citations Open access
Semantic Scholar
DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis
P. Vici, S. Buglioni, D. Sergi, L. Pizzuti +18 more
2016PLoS ONE15 citations Open access
Semantic Scholar
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin
M. Barba, L. Pizzuti, I. Sperduti, C. Natoli +18 more
2016Journal of Cellular Physiology15 citations
Semantic Scholar
Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave
A. Indini, G. Pinotti, Fabrizio Artioli, C. Aschele +15 more
2021European Journal of Cancer14 citations Open access
Semantic Scholar
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab
L. Pizzuti, D. Sergi, I. Sperduti, L. di Lauro +29 more
2018Cancer Biology & Therapy14 citations Open access
Semantic Scholar
Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: Results from a real word setting
L. Pizzuti, C. Natoli, T. Gamucci, Mariella Mauri +12 more
2017OncoTarget14 citations Open access
Semantic Scholar
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)
C. de Angelis, D. Bruzzese, A. Bernardo, E. Baldini +15 more
2020ESMO Open13 citations Open access
Semantic Scholar
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer
M. Barba, P. Vici, L. Pizzuti, L. di Lauro +14 more
2017BMC Cancer13 citations Open access
Semantic Scholar
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting
L. Pizzuti, E. Krasniqi, I. Sperduti, M. Barba +76 more
2021Therapeutic Advances in Medical Oncology12 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Vici×34
Invite
P. Vici — researcher profile on SciRah
C. Natoli×31
Invite
C. Natoli — researcher profile on SciRah
L. Pizzuti×30
Invite
L. Pizzuti — researcher profile on SciRah
M. Barba×28
Invite
M. Barba — researcher profile on SciRah

×23

Invite

P. Marchetti — researcher profile on SciRah

Invite

D. Sergi — researcher profile on SciRah

M. Maugeri-Saccà×20

Invite

M. Maugeri-Saccà — researcher profile on SciRah

A. Grassadonia×17

Invite

A. Grassadonia — researcher profile on SciRah

L. di Lauro×17

Invite

L. di Lauro — researcher profile on SciRah

L. Mentuccia×17

Invite

L. Mentuccia — researcher profile on SciRah

L. Moscetti×16

Invite

L. Moscetti — researcher profile on SciRah

Laura Iezzi×15

Invite

Laura Iezzi — researcher profile on SciRah